1. bookVolumen 42 (2021): Heft 2 (October 2021)
Zeitschriftendaten
License
Format
Zeitschrift
eISSN
1857-8985
Erstveröffentlichung
08 Sep 2014
Erscheinungsweise
2 Hefte pro Jahr
Sprachen
Englisch
access type Uneingeschränkter Zugang

Cancer – Associated Thrombosis – A Study of Cases

Zeitschriftendaten
License
Format
Zeitschrift
eISSN
1857-8985
Erstveröffentlichung
08 Sep 2014
Erscheinungsweise
2 Hefte pro Jahr
Sprachen
Englisch
Abstract

Research shows that the presence of cancer increases the likelihood of developing venous thromboembolism (pulmonary thromboembolism and deep vein thrombosis) from as much as fourfold up to sevenfold. It is imperative that after early diagnosis we treat cancer-associated thrombosis with grave seriousness in order to reduce its morbidity and mortality.

We present 14 case reports of patients with cancer-associated thrombosis including thrombosis related to malignant hemopathies.

1. 1. Iorga RA, Bratu OG, Marcu RD, et al. Venous thromboembolism in cancer patients: Still looking for answers. Exp Ther Med. 2019;18(6):5026-5032. doi:10.3892/etm.2019.801910.3892/etm.2019.8019 Search in Google Scholar

2. 2. Khorana AA, Noble S, Lee AYY, et al. Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH. J Thromb Haemost. 2018;16(9):1891-1894. doi:10.1111/jth.1421910.1111/jth.14219 Search in Google Scholar

3. 3.Streiff MB, Holmstrom B, Angelini D, et al. NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018. J Natl Compr Canc Netw. 2018;16(11):1289-1303. doi:10.6004/jnccn.2018.008410.6004/jnccn.2018.0084 Search in Google Scholar

4. 4. Trujillo-Santos J, Casas JM, Casado I, et al.RIETE Investigators. Thirty-day mortality rate in women with cancer and venous thromboembolism. Findings from the RIETE Registry. Thromb Res. 2011 Feb;127 Suppl 3:S1-4.10.1016/S0049-3848(11)00006-5 Search in Google Scholar

5. 5. Horowitz NA, Brenner B. Thrombosis in hematological malignancies: mechanisms and implications. Thromb Res. 2020 Jul;191 Suppl 1:S58-S62.10.1016/S0049-3848(20)30398-4 Search in Google Scholar

6. 6. Prandoni P, Lensing AW, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002;100(10):3484-3488. doi:10.1182/blood-2002-01-010810.1182/blood-2002-01-0108 Search in Google Scholar

7. 7. Mulder FI, Bosch FTM, Young AM, et al. Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis. Blood. 2020;136(12):1433-1441. doi:10.1182/blood.202000581910.1182/blood.2020005819 Search in Google Scholar

8. 8. Carrier M, Prandoni P. Controversies in the management of cancer-associated thrombosis. Expert Rev Hematol. 2017;10(1):15-22. doi:10.1080 /17474086.2017.125793510.1080/17474086.2017.1257935 Search in Google Scholar

9. 9. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603. doi:10.1093/eurheartj/ehz40510.1093/eurheartj/ehz405 Search in Google Scholar

Empfohlene Artikel von Trend MD

Planen Sie Ihre Fernkonferenz mit Scienceendo